{ "source": "Nasdaq Nordic Company News", "fetcher_build": "2026-08-03-nasdaq-cns-annual-period-v5.0.10", "status": "retrieved", "company": "Vitrolife AB", "reports": [ { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-03-nasdaq-cns-annual-period-v5.0.10", "retrieved_at": "2026-08-04T07:16:02Z", "company": "Vitrolife AB", "title": "Interim report Q2, 2026: Starka marginaler och god lönsamhet i en svag marknad", "category": "Halvårsrapport", "date": "2026-07-16", "language": "sv", "report_type": "interim-report", "fiscal_year": 2026, "quarter": "q2", "period": "2026-q2", "report_key": "2026:q2", "release_url": "https://view.news.eu.nasdaq.com/view?id=bf802871f5b8a9263adc3896b74049200&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\vitrolife-ab\\nasdaq-reports\\reports\\2026-q2\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\vitrolife-ab\\nasdaq-reports\\reports\\2026-q2\\release.txt", "attachments": [ { "label": "Delarsrapport Q2 2026.pdf", "url": "https://attachment.news.eu.nasdaq.com/ab20d45cdcd9425fcbb1e7037df9ec016", "final_url": "https://attachment.news.eu.nasdaq.com/ab20d45cdcd9425fcbb1e7037df9ec016", "filename": "Delarsrapport_Q2_2026.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\vitrolife-ab\\nasdaq-reports\\reports\\2026-q2\\Delarsrapport_Q2_2026.pdf", "content_type": "application/pdf", "size": 2612164, "sha256": "50f7d59c5effb5c8e8b205bc8f5627e558942c24528ae6336125f7b5ef654f2f", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\vitrolife-ab\\nasdaq-reports\\reports\\2026-q2\\Delarsrapport_Q2_2026.pdf", "filename": "Delarsrapport_Q2_2026.pdf", "extension": ".pdf", "size": 2612164, "sha256": "50f7d59c5effb5c8e8b205bc8f5627e558942c24528ae6336125f7b5ef654f2f", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\vitrolife-ab\\nasdaq-reports\\reports\\2026-q2\\extracted\\Delarsrapport_Q2_2026\\Delarsrapport_Q2_2026.txt", "text_chars": 63979, "metadata": { "page_count": 29, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\vitrolife-ab\\nasdaq-reports\\reports\\2026-q2\\extracted\\Delarsrapport_Q2_2026\\Delarsrapport_Q2_2026.extraction.json" } } ], "announcement_id": "1454336", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-03-nasdaq-cns-annual-period-v5.0.10", "retrieved_at": "2026-08-04T07:16:06Z", "company": "Vitrolife AB", "title": "Delårsrapport Q1, 2026: Stark tillväxt inom Consumables och Tehnologies", "category": "Interimsrapport", "date": "2026-04-23", "language": "sv", "report_type": "interim-report", "fiscal_year": 2026, "quarter": "q1", "period": "2026-q1", "report_key": "2026:q1", "release_url": "https://view.news.eu.nasdaq.com/view?id=b155dbd820b235c3157be99b436962eef&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\vitrolife-ab\\nasdaq-reports\\reports\\2026-q1\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\vitrolife-ab\\nasdaq-reports\\reports\\2026-q1\\release.txt", "attachments": [ { "label": "04222210.pdf", "url": "https://attachment.news.eu.nasdaq.com/a537075d186290467b0d983788603efb8", "final_url": "https://attachment.news.eu.nasdaq.com/a537075d186290467b0d983788603efb8", "filename": "04222210.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\vitrolife-ab\\nasdaq-reports\\reports\\2026-q1\\04222210.pdf", "content_type": "application/pdf", "size": 2524167, "sha256": "9e0e45ac91ae086fc07e070a27f6ffe65472abd3c7e09859df0c87d705b4ccfc", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\vitrolife-ab\\nasdaq-reports\\reports\\2026-q1\\04222210.pdf", "filename": "04222210.pdf", "extension": ".pdf", "size": 2524167, "sha256": "9e0e45ac91ae086fc07e070a27f6ffe65472abd3c7e09859df0c87d705b4ccfc", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\vitrolife-ab\\nasdaq-reports\\reports\\2026-q1\\extracted\\04222210\\04222210.txt", "text_chars": 54183, "metadata": { "page_count": 29, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\vitrolife-ab\\nasdaq-reports\\reports\\2026-q1\\extracted\\04222210\\04222210.extraction.json" } } ], "announcement_id": "1436364", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-03-nasdaq-cns-annual-period-v5.0.10", "retrieved_at": "2026-08-04T07:16:23Z", "company": "Vitrolife AB", "title": "Vitrolife Group har idag publicerat sin års- och hållbarhetsredovisning för 2025", "category": "Bokslut och Verksamhetsberättelse", "date": "2026-03-26", "language": "sv", "report_type": "annual-report", "fiscal_year": 2025, "quarter": "annual", "period": "2025-annual", "report_key": "2025:annual", "release_url": "https://view.news.eu.nasdaq.com/view?id=bdbae71384c9610157ad6f4d70c85a535&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\vitrolife-ab\\nasdaq-reports\\reports\\2025-annual\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\vitrolife-ab\\nasdaq-reports\\reports\\2025-annual\\release.txt", "attachments": [ { "label": "03238807.pdf", "url": "https://attachment.news.eu.nasdaq.com/a4acd4d9f1bc2630b3d49a514f3c80b6c", "final_url": "https://attachment.news.eu.nasdaq.com/a4acd4d9f1bc2630b3d49a514f3c80b6c", "filename": "03238807.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\vitrolife-ab\\nasdaq-reports\\reports\\2025-annual\\03238807.pdf", "content_type": "application/pdf", "size": 10303718, "sha256": "0d24f26eb73789c5a968debac3e9881e4e20b2b802ebf323809d98792b15d21a", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\vitrolife-ab\\nasdaq-reports\\reports\\2025-annual\\03238807.pdf", "filename": "03238807.pdf", "extension": ".pdf", "size": 10303718, "sha256": "0d24f26eb73789c5a968debac3e9881e4e20b2b802ebf323809d98792b15d21a", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\vitrolife-ab\\nasdaq-reports\\reports\\2025-annual\\extracted\\03238807\\03238807.txt", "text_chars": 566612, "metadata": { "page_count": 214, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\vitrolife-ab\\nasdaq-reports\\reports\\2025-annual\\extracted\\03238807\\03238807.extraction.json" } } ], "announcement_id": "1429098", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-03-nasdaq-cns-annual-period-v5.0.10", "retrieved_at": "2026-08-04T07:16:26Z", "company": "Vitrolife AB", "title": "Bokslutskommuniké 2025", "category": "Bokslutskommuniké", "date": "2026-02-03", "language": "sv", "report_type": "year-end-report", "fiscal_year": 2025, "quarter": "q4", "period": "2025-q4", "report_key": "2025:q4", "release_url": "https://view.news.eu.nasdaq.com/view?id=ba9c2793855f523961dff10700dca9825&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\vitrolife-ab\\nasdaq-reports\\reports\\2025-q4\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\vitrolife-ab\\nasdaq-reports\\reports\\2025-q4\\release.txt", "attachments": [ { "label": "02025068.pdf", "url": "https://attachment.news.eu.nasdaq.com/ab1865887ebbcc99d722c923a4c103e13", "final_url": "https://attachment.news.eu.nasdaq.com/ab1865887ebbcc99d722c923a4c103e13", "filename": "02025068.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\vitrolife-ab\\nasdaq-reports\\reports\\2025-q4\\02025068.pdf", "content_type": "application/pdf", "size": 2586675, "sha256": "71b8ac49e911f86a1cf96a2d4947c30f1e6c64875a03e088eccb935a7119a3dc", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\vitrolife-ab\\nasdaq-reports\\reports\\2025-q4\\02025068.pdf", "filename": "02025068.pdf", "extension": ".pdf", "size": 2586675, "sha256": "71b8ac49e911f86a1cf96a2d4947c30f1e6c64875a03e088eccb935a7119a3dc", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\vitrolife-ab\\nasdaq-reports\\reports\\2025-q4\\extracted\\02025068\\02025068.txt", "text_chars": 72526, "metadata": { "page_count": 30, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\vitrolife-ab\\nasdaq-reports\\reports\\2025-q4\\extracted\\02025068\\02025068.extraction.json" } } ], "announcement_id": "1417321", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-03-nasdaq-cns-annual-period-v5.0.10", "retrieved_at": "2026-08-04T07:16:31Z", "company": "Vitrolife AB", "title": "Delårsrapport Q3, 2025: Stark tillväxt i Americas", "category": "Interimsrapport", "date": "2025-10-23", "language": "sv", "report_type": "interim-report", "fiscal_year": 2025, "quarter": "q3", "period": "2025-q3", "report_key": "2025:q3", "release_url": "https://view.news.eu.nasdaq.com/view?id=bbc650d3ddf4f492af94bb57fbf9fd6dc&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\vitrolife-ab\\nasdaq-reports\\reports\\2025-q3\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\vitrolife-ab\\nasdaq-reports\\reports\\2025-q3\\release.txt", "attachments": [ { "label": "10227621.pdf", "url": "https://attachment.news.eu.nasdaq.com/a4aca834dcc13283a213ce3a55d51ad2e", "final_url": "https://attachment.news.eu.nasdaq.com/a4aca834dcc13283a213ce3a55d51ad2e", "filename": "10227621.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\vitrolife-ab\\nasdaq-reports\\reports\\2025-q3\\10227621.pdf", "content_type": "application/pdf", "size": 2816550, "sha256": "a72689c3155d7814affe032d52ff73029e4642e3bd20277f7d7876bbaf9fb76f", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\vitrolife-ab\\nasdaq-reports\\reports\\2025-q3\\10227621.pdf", "filename": "10227621.pdf", "extension": ".pdf", "size": 2816550, "sha256": "a72689c3155d7814affe032d52ff73029e4642e3bd20277f7d7876bbaf9fb76f", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\vitrolife-ab\\nasdaq-reports\\reports\\2025-q3\\extracted\\10227621\\10227621.txt", "text_chars": 66477, "metadata": { "page_count": 28, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\vitrolife-ab\\nasdaq-reports\\reports\\2025-q3\\extracted\\10227621\\10227621.extraction.json" } } ], "announcement_id": "1396112", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-03-nasdaq-cns-annual-period-v5.0.10", "retrieved_at": "2026-08-04T07:16:36Z", "company": "Vitrolife AB", "title": "Delårsrapport Q2, 2025: Stark tillväxt inom Consumables", "category": "Halvårsrapport", "date": "2025-07-17", "language": "sv", "report_type": "interim-report", "fiscal_year": 2025, "quarter": "q2", "period": "2025-q2", "report_key": "2025:q2", "release_url": "https://view.news.eu.nasdaq.com/view?id=b98367f55d484caf718419e264e4e040b&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\vitrolife-ab\\nasdaq-reports\\reports\\2025-q2\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\vitrolife-ab\\nasdaq-reports\\reports\\2025-q2\\release.txt", "attachments": [ { "label": "07160467.pdf", "url": "https://attachment.news.eu.nasdaq.com/a4cae554a1b285cdadb5f018f0d555a0a", "final_url": "https://attachment.news.eu.nasdaq.com/a4cae554a1b285cdadb5f018f0d555a0a", "filename": "07160467.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\vitrolife-ab\\nasdaq-reports\\reports\\2025-q2\\07160467.pdf", "content_type": "application/pdf", "size": 2225792, "sha256": "6d80a8080218b4eb04003994e2dfc7ce6ca544188015cbb505940df53e723420", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\vitrolife-ab\\nasdaq-reports\\reports\\2025-q2\\07160467.pdf", "filename": "07160467.pdf", "extension": ".pdf", "size": 2225792, "sha256": "6d80a8080218b4eb04003994e2dfc7ce6ca544188015cbb505940df53e723420", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\vitrolife-ab\\nasdaq-reports\\reports\\2025-q2\\extracted\\07160467\\07160467.txt", "text_chars": 64578, "metadata": { "page_count": 28, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\vitrolife-ab\\nasdaq-reports\\reports\\2025-q2\\extracted\\07160467\\07160467.extraction.json" } } ], "announcement_id": "1379559", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-03-nasdaq-cns-annual-period-v5.0.10", "retrieved_at": "2026-08-04T07:16:42Z", "company": "Vitrolife AB", "title": "Delårsrapport Q1, 2025: Starkt resultat i EMEA", "category": "Interimsrapport", "date": "2025-04-24", "language": "sv", "report_type": "interim-report", "fiscal_year": 2025, "quarter": "q1", "period": "2025-q1", "report_key": "2025:q1", "release_url": "https://view.news.eu.nasdaq.com/view?id=be03ecce90339f5c1b286565822ee282e&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\vitrolife-ab\\nasdaq-reports\\reports\\2025-q1\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\vitrolife-ab\\nasdaq-reports\\reports\\2025-q1\\release.txt", "attachments": [ { "label": "04241304.pdf", "url": "https://attachment.news.eu.nasdaq.com/a0b40903e0c9fe8159791a4d8f8081e13", "final_url": "https://attachment.news.eu.nasdaq.com/a0b40903e0c9fe8159791a4d8f8081e13", "filename": "04241304.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\vitrolife-ab\\nasdaq-reports\\reports\\2025-q1\\04241304.pdf", "content_type": "application/pdf", "size": 2230373, "sha256": "c8fb9660a6822397c289f5eaf5700cc6f92a35f984200d698f3d8e9b1869f345", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\vitrolife-ab\\nasdaq-reports\\reports\\2025-q1\\04241304.pdf", "filename": "04241304.pdf", "extension": ".pdf", "size": 2230373, "sha256": "c8fb9660a6822397c289f5eaf5700cc6f92a35f984200d698f3d8e9b1869f345", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\vitrolife-ab\\nasdaq-reports\\reports\\2025-q1\\extracted\\04241304\\04241304.txt", "text_chars": 54216, "metadata": { "page_count": 28, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\vitrolife-ab\\nasdaq-reports\\reports\\2025-q1\\extracted\\04241304\\04241304.extraction.json" } } ], "announcement_id": "1357651", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-03-nasdaq-cns-annual-period-v5.0.10", "retrieved_at": "2026-08-04T07:16:58Z", "company": "Vitrolife AB", "title": "Vitrolife Group Års- och hållbarhetsredovisning 2024", "category": "Bokslut och Verksamhetsberättelse", "date": "2025-03-27", "language": "sv", "report_type": "annual-report", "fiscal_year": 2024, "quarter": "annual", "period": "2024-annual", "report_key": "2024:annual", "release_url": "https://view.news.eu.nasdaq.com/view?id=b3af0c4e23a15931c8219e509a2579803&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\vitrolife-ab\\nasdaq-reports\\reports\\2024-annual\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\vitrolife-ab\\nasdaq-reports\\reports\\2024-annual\\release.txt", "attachments": [ { "label": "03266303.pdf", "url": "https://attachment.news.eu.nasdaq.com/a5c33b9a3e6bcfbf89603fae4182d114b", "final_url": "https://attachment.news.eu.nasdaq.com/a5c33b9a3e6bcfbf89603fae4182d114b", "filename": "03266303.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\vitrolife-ab\\nasdaq-reports\\reports\\2024-annual\\03266303.pdf", "content_type": "application/pdf", "size": 8107512, "sha256": "344174251ec1f8e3f1aec9778276f5ac109758e9d0970ce22e6c7529b7aedab7", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\vitrolife-ab\\nasdaq-reports\\reports\\2024-annual\\03266303.pdf", "filename": "03266303.pdf", "extension": ".pdf", "size": 8107512, "sha256": "344174251ec1f8e3f1aec9778276f5ac109758e9d0970ce22e6c7529b7aedab7", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\vitrolife-ab\\nasdaq-reports\\reports\\2024-annual\\extracted\\03266303\\03266303.txt", "text_chars": 493545, "metadata": { "page_count": 199, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\vitrolife-ab\\nasdaq-reports\\reports\\2024-annual\\extracted\\03266303\\03266303.extraction.json" } } ], "announcement_id": "1351637", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-03-nasdaq-cns-annual-period-v5.0.10", "retrieved_at": "2026-08-04T07:17:02Z", "company": "Vitrolife AB", "title": "Bokslutskommuniké 2024: En stark avslutning på året", "category": "Bokslutskommuniké", "date": "2025-01-30", "language": "sv", "report_type": "year-end-report", "fiscal_year": 2024, "quarter": "q4", "period": "2024-q4", "report_key": "2024:q4", "release_url": "https://view.news.eu.nasdaq.com/view?id=b58f92366305d6fb0b7854608297e40e3&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\vitrolife-ab\\nasdaq-reports\\reports\\2024-q4\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\vitrolife-ab\\nasdaq-reports\\reports\\2024-q4\\release.txt", "attachments": [ { "label": "01299476.pdf", "url": "https://attachment.news.eu.nasdaq.com/a289d491ecf94b8534e2dd68de8958411", "final_url": "https://attachment.news.eu.nasdaq.com/a289d491ecf94b8534e2dd68de8958411", "filename": "01299476.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\vitrolife-ab\\nasdaq-reports\\reports\\2024-q4\\01299476.pdf", "content_type": "application/pdf", "size": 3151418, "sha256": "c9d322a383f7741ad81f744d9412147adceb882da348e3ab108762eb399767ab", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\vitrolife-ab\\nasdaq-reports\\reports\\2024-q4\\01299476.pdf", "filename": "01299476.pdf", "extension": ".pdf", "size": 3151418, "sha256": "c9d322a383f7741ad81f744d9412147adceb882da348e3ab108762eb399767ab", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\vitrolife-ab\\nasdaq-reports\\reports\\2024-q4\\extracted\\01299476\\01299476.txt", "text_chars": 63780, "metadata": { "page_count": 27, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\vitrolife-ab\\nasdaq-reports\\reports\\2024-q4\\extracted\\01299476\\01299476.extraction.json" } } ], "announcement_id": "1339767", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-03-nasdaq-cns-annual-period-v5.0.10", "retrieved_at": "2026-08-04T07:17:07Z", "company": "Vitrolife AB", "title": "Delårsrapport Q3, 2024: Förbättrad tillväxt med solida marginaler", "category": "Interimsrapport", "date": "2024-10-24", "language": "sv", "report_type": "interim-report", "fiscal_year": 2024, "quarter": "q3", "period": "2024-q3", "report_key": "2024:q3", "release_url": "https://view.news.eu.nasdaq.com/view?id=be43466de7e2c16c42d2b9cc2f79eff49&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\vitrolife-ab\\nasdaq-reports\\reports\\2024-q3\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\vitrolife-ab\\nasdaq-reports\\reports\\2024-q3\\release.txt", "attachments": [ { "label": "10236544.pdf", "url": "https://attachment.news.eu.nasdaq.com/afdf76472a24cfd3acd708529c26c7e66", "final_url": "https://attachment.news.eu.nasdaq.com/afdf76472a24cfd3acd708529c26c7e66", "filename": "10236544.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\vitrolife-ab\\nasdaq-reports\\reports\\2024-q3\\10236544.pdf", "content_type": "application/pdf", "size": 3138736, "sha256": "645c83feb650b47b7e074e248fee4b9fabaaec739f3b4acd74c600143e65f75b", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\vitrolife-ab\\nasdaq-reports\\reports\\2024-q3\\10236544.pdf", "filename": "10236544.pdf", "extension": ".pdf", "size": 3138736, "sha256": "645c83feb650b47b7e074e248fee4b9fabaaec739f3b4acd74c600143e65f75b", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\vitrolife-ab\\nasdaq-reports\\reports\\2024-q3\\extracted\\10236544\\10236544.txt", "text_chars": 65525, "metadata": { "page_count": 27, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\vitrolife-ab\\nasdaq-reports\\reports\\2024-q3\\extracted\\10236544\\10236544.extraction.json" } } ], "announcement_id": "1323232", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-03-nasdaq-cns-annual-period-v5.0.10", "retrieved_at": "2026-08-04T07:17:12Z", "company": "Vitrolife AB", "title": "Delårsrapport Q2, 2024: Stark tillväxt inom Technologies och förbättrade marginaler", "category": "Halvårsrapport", "date": "2024-07-17", "language": "sv", "report_type": "interim-report", "fiscal_year": 2024, "quarter": "q2", "period": "2024-q2", "report_key": "2024:q2", "release_url": "https://view.news.eu.nasdaq.com/view?id=ba6b95e0ee94880319e886da4f4ffbd06&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\vitrolife-ab\\nasdaq-reports\\reports\\2024-q2\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\vitrolife-ab\\nasdaq-reports\\reports\\2024-q2\\release.txt", "attachments": [ { "label": "07166307.pdf", "url": "https://attachment.news.eu.nasdaq.com/acc37085d891dd34726f3aed17fae7634", "final_url": "https://attachment.news.eu.nasdaq.com/acc37085d891dd34726f3aed17fae7634", "filename": "07166307.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\vitrolife-ab\\nasdaq-reports\\reports\\2024-q2\\07166307.pdf", "content_type": "application/pdf", "size": 2626600, "sha256": "81aa3cbb43b38e0fc357041052385314186d5475484a70552596fa2bae7ed5d7", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\vitrolife-ab\\nasdaq-reports\\reports\\2024-q2\\07166307.pdf", "filename": "07166307.pdf", "extension": ".pdf", "size": 2626600, "sha256": "81aa3cbb43b38e0fc357041052385314186d5475484a70552596fa2bae7ed5d7", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\vitrolife-ab\\nasdaq-reports\\reports\\2024-q2\\extracted\\07166307\\07166307.txt", "text_chars": 64225, "metadata": { "page_count": 27, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\vitrolife-ab\\nasdaq-reports\\reports\\2024-q2\\extracted\\07166307\\07166307.extraction.json" } } ], "announcement_id": "1306799", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-03-nasdaq-cns-annual-period-v5.0.10", "retrieved_at": "2026-08-04T07:17:17Z", "company": "Vitrolife AB", "title": "Delårsrapport Q1, 2024: Stark tillväxt i APAC och stabila marginaler", "category": "Interimsrapport", "date": "2024-04-18", "language": "sv", "report_type": "interim-report", "fiscal_year": 2024, "quarter": "q1", "period": "2024-q1", "report_key": "2024:q1", "release_url": "https://view.news.eu.nasdaq.com/view?id=bdc6a94627838ba68d7e78bf6e75fdd5c&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\vitrolife-ab\\nasdaq-reports\\reports\\2024-q1\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\vitrolife-ab\\nasdaq-reports\\reports\\2024-q1\\release.txt", "attachments": [ { "label": "04173466.pdf", "url": "https://attachment.news.eu.nasdaq.com/a24c29f8357ce3151c4896a7e995a1bf7", "final_url": "https://attachment.news.eu.nasdaq.com/a24c29f8357ce3151c4896a7e995a1bf7", "filename": "04173466.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\vitrolife-ab\\nasdaq-reports\\reports\\2024-q1\\04173466.pdf", "content_type": "application/pdf", "size": 2129465, "sha256": "1de97307c4a6e002f2acbfe0f69c053b3c9d3b2405b5a1202ba2cc81f9e1d5fe", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\vitrolife-ab\\nasdaq-reports\\reports\\2024-q1\\04173466.pdf", "filename": "04173466.pdf", "extension": ".pdf", "size": 2129465, "sha256": "1de97307c4a6e002f2acbfe0f69c053b3c9d3b2405b5a1202ba2cc81f9e1d5fe", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\vitrolife-ab\\nasdaq-reports\\reports\\2024-q1\\extracted\\04173466\\04173466.txt", "text_chars": 54610, "metadata": { "page_count": 25, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\vitrolife-ab\\nasdaq-reports\\reports\\2024-q1\\extracted\\04173466\\04173466.extraction.json" } } ], "announcement_id": "1288654", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-03-nasdaq-cns-annual-period-v5.0.10", "retrieved_at": "2026-08-04T07:17:32Z", "company": "Vitrolife AB", "title": "Vitrolife Group Års- och hållbarhetsredovisning 2023", "category": "Bokslut och Verksamhetsberättelse", "date": "2024-03-27", "language": "sv", "report_type": "annual-report", "fiscal_year": 2023, "quarter": "annual", "period": "2023-annual", "report_key": "2023:annual", "release_url": "https://view.news.eu.nasdaq.com/view?id=b180154771fc4e7d0a9f729ceffd03f40&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\vitrolife-ab\\nasdaq-reports\\reports\\2023-annual\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\vitrolife-ab\\nasdaq-reports\\reports\\2023-annual\\release.txt", "attachments": [ { "label": "03262421.pdf", "url": "https://attachment.news.eu.nasdaq.com/aabaa3b0d02d80f14b410effc3c4198d1", "final_url": "https://attachment.news.eu.nasdaq.com/aabaa3b0d02d80f14b410effc3c4198d1", "filename": "03262421.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\vitrolife-ab\\nasdaq-reports\\reports\\2023-annual\\03262421.pdf", "content_type": "application/pdf", "size": 9110174, "sha256": "0bbc95f3e178c9b290c20b5d8a11f951dd9c3d347fd5afc5845eda8514e24fbb", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\vitrolife-ab\\nasdaq-reports\\reports\\2023-annual\\03262421.pdf", "filename": "03262421.pdf", "extension": ".pdf", "size": 9110174, "sha256": "0bbc95f3e178c9b290c20b5d8a11f951dd9c3d347fd5afc5845eda8514e24fbb", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\vitrolife-ab\\nasdaq-reports\\reports\\2023-annual\\extracted\\03262421\\03262421.txt", "text_chars": 380933, "metadata": { "page_count": 158, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\vitrolife-ab\\nasdaq-reports\\reports\\2023-annual\\extracted\\03262421\\03262421.extraction.json" } } ], "announcement_id": "1284177", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-03-nasdaq-cns-annual-period-v5.0.10", "retrieved_at": "2026-08-04T07:17:35Z", "company": "Vitrolife AB", "title": "Bokslutskommuniké 2023: Fortsatt tillväxt med marginalförbättringar", "category": "Bokslutskommuniké", "date": "2024-02-02", "language": "sv", "report_type": "year-end-report", "fiscal_year": 2023, "quarter": "q4", "period": "2023-q4", "report_key": "2023:q4", "release_url": "https://view.news.eu.nasdaq.com/view?id=b010fd41b3f836d21b3b4caa791b2aa84&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\vitrolife-ab\\nasdaq-reports\\reports\\2023-q4\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\vitrolife-ab\\nasdaq-reports\\reports\\2023-q4\\release.txt", "attachments": [ { "label": "02010921.pdf", "url": "https://attachment.news.eu.nasdaq.com/a0731b342633ec2e7abf43787dc2b7582", "final_url": "https://attachment.news.eu.nasdaq.com/a0731b342633ec2e7abf43787dc2b7582", "filename": "02010921.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\vitrolife-ab\\nasdaq-reports\\reports\\2023-q4\\02010921.pdf", "content_type": "application/pdf", "size": 3242103, "sha256": "6b748e889ab39ac8e3f5178a8377d869796c82a079937acd8c63e63debeaea0e", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\vitrolife-ab\\nasdaq-reports\\reports\\2023-q4\\02010921.pdf", "filename": "02010921.pdf", "extension": ".pdf", "size": 3242103, "sha256": "6b748e889ab39ac8e3f5178a8377d869796c82a079937acd8c63e63debeaea0e", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\vitrolife-ab\\nasdaq-reports\\reports\\2023-q4\\extracted\\02010921\\02010921.txt", "text_chars": 61930, "metadata": { "page_count": 27, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\vitrolife-ab\\nasdaq-reports\\reports\\2023-q4\\extracted\\02010921\\02010921.extraction.json" } } ], "announcement_id": "1272363", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-03-nasdaq-cns-annual-period-v5.0.10", "retrieved_at": "2026-08-04T07:17:39Z", "company": "Vitrolife AB", "title": "Delårsrapport Q3, 2023: Lönsam global tillväxt trots motvind i USA", "category": "Interimsrapport", "date": "2023-10-27", "language": "sv", "report_type": "interim-report", "fiscal_year": 2023, "quarter": "q3", "period": "2023-q3", "report_key": "2023:q3", "release_url": "https://view.news.eu.nasdaq.com/view?id=b2337d41be1cecb86a4a947d07c4a554a&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\vitrolife-ab\\nasdaq-reports\\reports\\2023-q3\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\vitrolife-ab\\nasdaq-reports\\reports\\2023-q3\\release.txt", "attachments": [ { "label": "10262915.pdf", "url": "https://attachment.news.eu.nasdaq.com/afaecf8a8f97b8015315ae71529a11ce7", "final_url": "https://attachment.news.eu.nasdaq.com/afaecf8a8f97b8015315ae71529a11ce7", "filename": "10262915.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\vitrolife-ab\\nasdaq-reports\\reports\\2023-q3\\10262915.pdf", "content_type": "application/pdf", "size": 2201562, "sha256": "8d00daa179fa7d66a020bb4751cc3f387a69c6e1ad1eb981de4129a03370a15a", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\vitrolife-ab\\nasdaq-reports\\reports\\2023-q3\\10262915.pdf", "filename": "10262915.pdf", "extension": ".pdf", "size": 2201562, "sha256": "8d00daa179fa7d66a020bb4751cc3f387a69c6e1ad1eb981de4129a03370a15a", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\vitrolife-ab\\nasdaq-reports\\reports\\2023-q3\\extracted\\10262915\\10262915.txt", "text_chars": 64552, "metadata": { "page_count": 26, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\vitrolife-ab\\nasdaq-reports\\reports\\2023-q3\\extracted\\10262915\\10262915.extraction.json" } } ], "announcement_id": "1255441", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-03-nasdaq-cns-annual-period-v5.0.10", "retrieved_at": "2026-08-04T07:17:44Z", "company": "Vitrolife AB", "title": "Delårsrapport Q2, 2023: Stark tillväxt i APAC", "category": "Halvårsrapport", "date": "2023-07-14", "language": "sv", "report_type": "interim-report", "fiscal_year": 2023, "quarter": "q2", "period": "2023-q2", "report_key": "2023:q2", "release_url": "https://view.news.eu.nasdaq.com/view?id=bbb3eea0dcf8acea75786f4be62794a06&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\vitrolife-ab\\nasdaq-reports\\reports\\2023-q2\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\vitrolife-ab\\nasdaq-reports\\reports\\2023-q2\\release.txt", "attachments": [ { "label": "07133335.pdf", "url": "https://attachment.news.eu.nasdaq.com/a4ea38d714566691b479da9073ee6b6ac", "final_url": "https://attachment.news.eu.nasdaq.com/a4ea38d714566691b479da9073ee6b6ac", "filename": "07133335.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\vitrolife-ab\\nasdaq-reports\\reports\\2023-q2\\07133335.pdf", "content_type": "application/pdf", "size": 2174725, "sha256": "8acd309083c43b6ec28c1bb3b2fda8d77dcc51785c28166bcad326385f467390", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\vitrolife-ab\\nasdaq-reports\\reports\\2023-q2\\07133335.pdf", "filename": "07133335.pdf", "extension": ".pdf", "size": 2174725, "sha256": "8acd309083c43b6ec28c1bb3b2fda8d77dcc51785c28166bcad326385f467390", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\vitrolife-ab\\nasdaq-reports\\reports\\2023-q2\\extracted\\07133335\\07133335.txt", "text_chars": 59393, "metadata": { "page_count": 26, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\vitrolife-ab\\nasdaq-reports\\reports\\2023-q2\\extracted\\07133335\\07133335.extraction.json" } } ], "announcement_id": "1238389", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-03-nasdaq-cns-annual-period-v5.0.10", "retrieved_at": "2026-08-04T07:17:50Z", "company": "Vitrolife AB", "title": "Delårsrapport Q1, 2023: Bra start på året", "category": "Interimsrapport", "date": "2023-04-21", "language": "sv", "report_type": "interim-report", "fiscal_year": 2023, "quarter": "q1", "period": "2023-q1", "report_key": "2023:q1", "release_url": "https://view.news.eu.nasdaq.com/view?id=b54c5e6890d3b416e515de260d3200509&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\vitrolife-ab\\nasdaq-reports\\reports\\2023-q1\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\vitrolife-ab\\nasdaq-reports\\reports\\2023-q1\\release.txt", "attachments": [ { "label": "04203188.pdf", "url": "https://attachment.news.eu.nasdaq.com/ac486bc559442250f6f238069d488775a", "final_url": "https://attachment.news.eu.nasdaq.com/ac486bc559442250f6f238069d488775a", "filename": "04203188.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\vitrolife-ab\\nasdaq-reports\\reports\\2023-q1\\04203188.pdf", "content_type": "application/pdf", "size": 2854862, "sha256": "b485113b5c47f269af2b5aa398f0288059202523d61d736ea6768f98ac81ef5d", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\vitrolife-ab\\nasdaq-reports\\reports\\2023-q1\\04203188.pdf", "filename": "04203188.pdf", "extension": ".pdf", "size": 2854862, "sha256": "b485113b5c47f269af2b5aa398f0288059202523d61d736ea6768f98ac81ef5d", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\vitrolife-ab\\nasdaq-reports\\reports\\2023-q1\\extracted\\04203188\\04203188.txt", "text_chars": 50885, "metadata": { "page_count": 24, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\vitrolife-ab\\nasdaq-reports\\reports\\2023-q1\\extracted\\04203188\\04203188.extraction.json" } } ], "announcement_id": "1221415", "status": "retrieved" } ], "attempts": [ { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Vitrolife&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "sv", "start": 0, "pagination": "row-offset", "query_text": "Vitrolife", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "de0ff7f6667cc18ee145a0bba587496a1ec4f6d158fb68bbc2b833f484bcd9aa" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Vitrolife&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=100&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "sv", "start": 100, "pagination": "row-offset", "query_text": "Vitrolife", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "a7d8395316bac70681f2150140624c3b82864d637d65e027bcf78a235439e8cc" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Vitrolife&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=200&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "sv", "start": 200, "pagination": "row-offset", "query_text": "Vitrolife", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "8afea548126bb582b43d82f5b2dadf23f1ed027d08c0c332b29fcc8c74722686" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Vitrolife&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=300&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "sv", "start": 300, "pagination": "row-offset", "query_text": "Vitrolife", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "216f7c7ceb209adaf2f3cc803ce2007b68bdfab1939f92415236bb8de533b1f4" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Vitrolife&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=400&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "sv", "start": 400, "pagination": "row-offset", "query_text": "Vitrolife", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "9dc10efcf704d7213bdffc22e234a3366e04856e70a525e6df0cc56788c91c16" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Vitrolife&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=500&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "sv", "start": 500, "pagination": "row-offset", "query_text": "Vitrolife", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 43, "new_rows": 43, "total_count": null, "from_cache": false, "body_sha256": "0da5d152bee8a54f6e962b633656e04e57ba8df8c2625f95e410f70326f4fb71" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Vitrolife&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC", "status": 200, "scope": "NordicFirstNorth", "language": "sv", "start": 0, "pagination": "row-offset", "query_text": "Vitrolife", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 26, "new_rows": 26, "total_count": null, "from_cache": false, "body_sha256": "052e5cda76f6d5384c58bbe29cbb9347d1ae1efe39087bb88718da978779703d" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Vitrolife&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=26&dir=DESC", "status": 200, "scope": "NordicFirstNorth", "language": "sv", "start": 26, "pagination": "row-offset", "query_text": "Vitrolife", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 0, "new_rows": 0, "total_count": null, "from_cache": false, "body_sha256": "b1c2da79a54760df102f0862688713eeec2f976749f274f87bd3e76598a6b5f4" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Vitrolife&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "en", "start": 0, "pagination": "row-offset", "query_text": "Vitrolife", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "8f72d318d1dc81e341fe52d5e6a6bf7dc83a498d3a64553ea9e6db03a4d603b2" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Vitrolife&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=100&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "en", "start": 100, "pagination": "row-offset", "query_text": "Vitrolife", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "b1fb519fee260cfca516f43bbe16086bd897018980b8947fd52a3156b5345f2f" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Vitrolife&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=200&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "en", "start": 200, "pagination": "row-offset", "query_text": "Vitrolife", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "601ec870adffc9d1767315f87c7d5f2733836b403995bfa72793c2f8b133bac6" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Vitrolife&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=300&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "en", "start": 300, "pagination": "row-offset", "query_text": "Vitrolife", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "47b9c264470c17b5389a2f1be721d8a5a8d0430f35ed4324ea8315e141b9f5bb" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Vitrolife&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=400&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "en", "start": 400, "pagination": "row-offset", "query_text": "Vitrolife", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 74, "new_rows": 74, "total_count": null, "from_cache": false, "body_sha256": "f3128b55993e3cfef8fc65e75be6f2d8871ee579a080d48dd234cbf6511564d7" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Vitrolife&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=474&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "en", "start": 474, "pagination": "row-offset", "query_text": "Vitrolife", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 0, "new_rows": 0, "total_count": null, "from_cache": false, "body_sha256": "5c13587def72d866e1b203d4fa4b0b697d13caede1b5463a05c8e4af8633d2ca" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Vitrolife&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC", "status": 200, "scope": "NordicFirstNorth", "language": "en", "start": 0, "pagination": "row-offset", "query_text": "Vitrolife", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 10, "new_rows": 10, "total_count": null, "from_cache": false, "body_sha256": "bf9615093c3b0d0fc4f4885a8c11767fb8eb94a05596c7861b231e79adfdfcb2" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Vitrolife&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=10&dir=DESC", "status": 200, "scope": "NordicFirstNorth", "language": "en", "start": 10, "pagination": "row-offset", "query_text": "Vitrolife", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 0, "new_rows": 0, "total_count": null, "from_cache": false, "body_sha256": "87075935338047732b46bc1bf687a741060a837b5bd1d14a390a71bc919e17dc" } ], "identity": { "slug": "vitr", "instrument_id": "TX354", "resolved_url": "https://www.nasdaq.com/european-market-activity/shares/vitr?id=TX354" }, "transport": "ordinary-http", "browser_used": false, "query_text": "Vitrolife", "retrieved_at": "2026-08-04T07:17:50Z" }